Skip to main content

Find Clinical Trials

Home
Conditions
Adrenal Cortex Neoplasms

Clinical trial condition

Adrenal Cortex Neoplasms

Explore clinical trials studying Adrenal Cortex Neoplasms. Study availability and eligibility vary by location and protocol.

76 public trials 22 recruiting studies

Refine in advanced search Browse all conditions

Adrenal Cortex Neoplasms trial results

Active, Not Recruiting

Evaluation of Side Effects of Mitotane

NCT00568139

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
Locations: University Hospital Würzburg, Germany

View Trial Details

Active, Not Recruiting

Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma

NCT03127774

Conditions: Abdominal Neoplasms, Adenocarcinoma, Adrenal Cortex Diseases, +16 more
Locations: Columbia University Medical Center New York, United States

View Trial Details

Active, Not Recruiting

Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma

NCT02673333

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
Locations: University of Michigan (Data or Specimen Analysis Only) Ann Arbor, Michigan, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)

NCT04358107

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)

NCT03833700

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +30 more
Locations: Eisai Trial Site#7 Nagoya, Aichi-ken, Japan

Eisai Trial Site #2 Kashiwa, Chiba, Japan

Eisai Trial Site #5 Sapporo, Hokkaido, Japan

Eisai Trial Site#8 Sendai, Miyagi, Japan

View Trial Details

Active, Not Recruiting

Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical Carcinoma

NCT05036434

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
Locations: National Cancer Center Goyang-si, Gyeonggi-do, South Korea

View Trial Details